JPY 2020.0
(0.65%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.36 Billion JPY | 37.85% |
2022 | 1.48 Billion JPY | -40.95% |
2021 | 2.43 Billion JPY | -20.39% |
2020 | 2.05 Billion JPY | 38.88% |
2019 | 2.17 Billion JPY | 30.07% |
2018 | 1.73 Billion JPY | 11.88% |
2017 | 1.53 Billion JPY | 6.65% |
2016 | 1.43 Billion JPY | 29.25% |
2015 | 1.11 Billion JPY | -15.76% |
2014 | 1.4 Billion JPY | -4.84% |
2013 | 1.43 Billion JPY | 4.95% |
2012 | 1.32 Billion JPY | 8.39% |
2011 | 1.24 Billion JPY | -8.29% |
2010 | 1.31 Billion JPY | -29.22% |
2009 | 1.42 Billion JPY | 66.93% |
2008 | 947.46 Million JPY | -7.7% |
2007 | 958.5 Million JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 564 Million JPY | 3.68% |
2023 FY | - JPY | 37.85% |
2023 Q1 | 304.71 Million JPY | 197.12% |
2023 Q4 | 520.68 Million JPY | -9.53% |
2023 Q3 | 575.54 Million JPY | 65.25% |
2023 Q2 | 348.28 Million JPY | 14.3% |
2022 Q1 | 369.36 Million JPY | -5.57% |
2022 Q2 | 253.96 Million JPY | -31.24% |
2022 Q3 | 169.82 Million JPY | -33.13% |
2022 Q4 | 102.55 Million JPY | -39.61% |
2022 FY | - JPY | -40.95% |
2021 Q3 | 511.84 Million JPY | -6.97% |
2021 FY | - JPY | -20.39% |
2021 Q1 | 416.92 Million JPY | 17.02% |
2021 Q2 | 550.18 Million JPY | 31.96% |
2021 Q4 | 391.16 Million JPY | -23.58% |
2020 Q3 | 586.87 Million JPY | -30.53% |
2020 Q2 | 844.76 Million JPY | 20.33% |
2020 Q1 | 702.02 Million JPY | 98.58% |
2020 Q4 | 356.29 Million JPY | -39.29% |
2020 FY | - JPY | 38.88% |
2019 Q1 | 295.78 Million JPY | -20.32% |
2019 Q2 | 424.01 Million JPY | 43.35% |
2019 Q3 | 593.79 Million JPY | 40.04% |
2019 FY | - JPY | 30.07% |
2019 Q4 | 353.52 Million JPY | -40.46% |
2018 Q3 | 330.09 Million JPY | 19.29% |
2018 FY | - JPY | 11.88% |
2018 Q1 | 238.09 Million JPY | -9.92% |
2018 Q2 | 276.7 Million JPY | 16.21% |
2018 Q4 | 371.23 Million JPY | 12.47% |
2017 Q1 | 193.22 Million JPY | -4.68% |
2017 Q3 | 341.36 Million JPY | 2.95% |
2017 Q4 | 264.32 Million JPY | -22.57% |
2017 Q2 | 331.58 Million JPY | 71.6% |
2017 FY | - JPY | 6.65% |
2016 FY | - JPY | 29.25% |
2016 Q1 | 196.05 Million JPY | 308.18% |
2016 Q2 | 383.75 Million JPY | 95.73% |
2016 Q3 | 328.04 Million JPY | -14.52% |
2016 Q4 | 202.72 Million JPY | -38.2% |
2015 FY | - JPY | -15.76% |
2015 Q4 | 48.03 Million JPY | -83.34% |
2015 Q3 | 288.25 Million JPY | 11.06% |
2015 Q2 | 259.54 Million JPY | 131.31% |
2015 Q1 | 112.2 Million JPY | -59.16% |
2014 FY | - JPY | -4.84% |
2014 Q1 | 92.25 Million JPY | -54.01% |
2014 Q3 | 237.52 Million JPY | -4.24% |
2014 Q2 | 248.03 Million JPY | 168.85% |
2014 Q4 | 274.73 Million JPY | 15.67% |
2013 FY | - JPY | 4.95% |
2013 Q3 | 264.17 Million JPY | 26.61% |
2013 Q2 | 208.64 Million JPY | 77.37% |
2013 Q4 | 200.62 Million JPY | -24.06% |
2013 Q1 | 117.63 Million JPY | -30.06% |
2012 Q2 | 223.77 Million JPY | 130.52% |
2012 Q3 | 194.12 Million JPY | -13.25% |
2012 Q4 | 168.2 Million JPY | -13.35% |
2012 FY | - JPY | 8.39% |
2012 Q1 | 97.07 Million JPY | -19.42% |
2011 Q4 | 120.47 Million JPY | -19.35% |
2011 FY | - JPY | -8.29% |
2011 Q3 | 149.36 Million JPY | -20.08% |
2011 Q2 | 186.89 Million JPY | 278.39% |
2011 Q1 | 49.39 Million JPY | -80.9% |
2010 Q1 | 270.92 Million JPY | -42.87% |
2010 Q4 | 258.61 Million JPY | -35.32% |
2010 FY | - JPY | -29.22% |
2010 Q3 | 399.82 Million JPY | -2.87% |
2010 Q2 | 411.62 Million JPY | 51.93% |
2009 Q3 | 261.72 Million JPY | 0.0% |
2009 Q4 | 474.2 Million JPY | 81.19% |
2009 FY | - JPY | 66.93% |
2008 Q2 | 105.73 Million JPY | 0.0% |
2008 Q3 | 257.53 Million JPY | 143.56% |
2008 Q4 | 472.36 Million JPY | 83.41% |
2008 FY | - JPY | -7.7% |
2007 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Kitanotatsujin Corporation | 1.58 Billion JPY | 13.753% |
Euglena Co., Ltd. | 676 Million JPY | -102.592% |
BEAUTY GARAGE Inc. | 1.96 Billion JPY | 30.298% |
Axas Holdings Co.,Ltd. | 555.75 Million JPY | -146.424% |
C.I. Medical Co.,Ltd. | 4.01 Billion JPY | 65.873% |
Kao Corporation | 154.49 Billion JPY | 99.114% |
Rohto Pharmaceutical Co.,Ltd. | 48.85 Billion JPY | 97.197% |
Shiseido Company, Limited | 106.46 Billion JPY | 98.714% |
Lion Corporation | 42.31 Billion JPY | 96.763% |
Mandom Corporation | 6.69 Billion JPY | 79.556% |
Ivy Cosmetics Corporation | 242.6 Million JPY | -464.519% |
Milbon Co., Ltd. | 7.8 Billion JPY | 82.443% |
Nippon Shikizai, Inc. | 1.28 Billion JPY | -6.282% |
Fancl Corporation | 16.6 Billion JPY | 91.751% |
KOSÉ Corporation | 26.85 Billion JPY | 94.901% |
Cota Co., Ltd. | 2.26 Billion JPY | 39.628% |
HABA Laboratories,Inc. | -1.31 Billion JPY | 204.201% |
C'bon Cosmetics Co.,Ltd. | 171.84 Million JPY | -696.943% |
Pola Orbis Holdings Inc. | 23.17 Billion JPY | 94.091% |
Noevir Holdings Co., Ltd. | 12.24 Billion JPY | 88.815% |
Adjuvant Holdings Co.,Ltd. | 124 Million JPY | -1004.454% |
Almado, Inc. | 983.21 Million JPY | -39.29% |
I-ne CO., LTD. | 4.7 Billion JPY | 70.861% |
Premier Anti-Aging Co., Ltd. | -627 Million JPY | 318.425% |
Liberta Co.,Ltd. | 318.19 Million JPY | -330.408% |
AXXZIA Inc. | 1.28 Billion JPY | -6.453% |
S.T. Corporation | 2.62 Billion JPY | 47.848% |
Kobayashi Pharmaceutical Co., Ltd. | 31.68 Billion JPY | 95.678% |
Earth Corporation | 10.6 Billion JPY | 87.09% |
Sagami Rubber Industries Co., Ltd. | 1.09 Billion JPY | -25.122% |
Asahi Eito Holdings Co.,Ltd. | -573.98 Million JPY | 338.601% |
Ya-Man Ltd. | 1.43 Billion JPY | 4.68% |
MTG Co., Ltd. | 4.39 Billion JPY | 68.832% |
TRANSACTION CO.,Ltd. | 5.8 Billion JPY | 76.425% |
SHOBIDO Corporation | 1.11 Billion JPY | -23.359% |
Artnature Inc. | 3.78 Billion JPY | 63.836% |
Pigeon Corporation | 15.8 Billion JPY | 91.335% |
Unicharm Corporation | 178.01 Billion JPY | 99.231% |
Paltac Corporation | 35.92 Billion JPY | 96.188% |
CB GROUP MANAGEMENT Co., Ltd. | 3.28 Billion JPY | 58.31% |